Firalis Molecular Precision

Save 15% off all proteomics analyses using the advanced Olink Proteomics Explore HT platform until December 2024, and kickstart 2025 with cutting-edge insights! By quantifying 5,400 protein biomarkers simultaneously in only 2 µl of sample, the Olink® Explore HT platform empowers your biomarker discovery studies across neurology, immunology and oncology. So take advantage of this limited-time offer to accelerate your biomarker discovery efforts with the support of our proteomics experts. Why choose Firalis Molecular Precision's services? • Matrix validation: plasma, serum, CSF, urine, and more. • Bioinformatics support: pathways analysis, differential expression, and group clustering. • Fast turnaround time: Receive your data in as little as 2 weeks from sample reception. Contact us at sales@firalis.com for detailed information and claim your discount before December 31, 2024. #BiomarkerDiscovery #Proteomics #Olink #Discount #DataAnalysis #DrugDevelopment

The holiday season is in full swing at Firalis Molecular Precision! 🎅 We organized a #SecretSanta gift exchange to spread good vibes and celebrate each other before the holidays. Wishing everyone a wonderful holiday season filled with warmth and happiness! 🎄

[A Word From Our CEO] As 2024 comes to a close, I want to express my heartfelt gratitude to those who make our success possible this year again. The trust and confidence of our clients who have fueled our growth, and the increasing volume of analyses they’ve entrusted to us reflects the strength of our partnerships. The dedication, expertise, and passion of all members of Firalis Molecular Precision inspire me every day. I’m proud to work alongside such a talented group of professionals. This year’s achievements are a testament to what we can accomplish together. Here’s to an even more successful and inspiring 2025! Thank you all for your trust and collaboration.

As 2024 wraps up, we reflect on a year filled with growth, innovation, and impactful results!   This year, we expanded our product portfolio by adding cutting-edge platforms like the Illumina NovaSeq X Plus and Olink Proteomics Signature Q100 to our labs. We also earned ISO 20387:2018 certification, further elevating our commitment to quality, and this was made possible by the dedication and hard work of our quality team. We’ve managed over 150 projects and analyzed more than 15,000 samples—a true testament to the trust our clients place in us and the valuable partnerships we’ve built. We are proud to be helping streamline drug development and accelerate research. We also had the opportunity to engage directly with our clients through our first Lunch & Learn with Olink Proteomics and our first webinar with SPT Labtech, which allowed us to better understand our clients’ needs and research goals and better align our services with their mission to innovate and improve patient treatment and care. We proudly selected Vincent Anquetil, PhD, Director of Translational Data Science at Alentis Therapeutics, as the winner of our Spatial Omics Grant Program. We’re excited to support his transformative work in cancer immunotherapy using Vizgen technology. We look forward to continuing our work in 2025, supporting our clients in delivering breakthrough therapies that will improve patient outcomes globally!

At Firalis Molecular Precision, we combine cutting-edge technologies with advanced analytical expertise to provide top-tier bioinformatics solutions for our clients. Today, we’re answering one of the most common questions we receive about our bioinformatics services: What advanced technologies and analyses do we specialize in? Stay tuned as we address more of your frequently asked questions in our upcoming posts. Have a question you’d like us to cover? Let us know in the comments! #Bioinformatics #FAQ #DataAnalysis #PrimaryAnalysis #SecondaryAnalysis

We are proud to have supported the Edward Smith Laboratory at Boston Children's Hospital in their innovative research exploring the role of Lectin-type oxidized LDL receptor-1 (LOX-1) in cerebral cavernous malformations (CCM), a condition impacting the central nervous system. By leveraging the Olink Proteomics Explore 3072-Plex Panel, our proteomics team contributed critical data on protein expression in urine samples. These findings, published in Frontiers in Neuroscience, advance understanding of LOX-1 as a biomarker and therapeutic target for CCM. Congratulations to the authors on this significant achievement! Read the full paper here: https://lnkd.in/dqRkGydN #Proteomics #Neuroscience #Innovation #CCM #Research

We’re at BioFIT 2024 in Lille, France! Our CEO, David Halter, PhD, and Business Development Manager, Marjolaine Rouard, are on-site at BioFIT, sharing Booth D46 with our partners at Olink Proteomics to showcase our innovative, multiomics-based bioanalytical solutions 🧬🔬. We’re eager to connect with experts, explore potential collaborations, and discuss how our solutions are driving progress in life sciences and healthcare. If you’re attending BioFIT, stop by Booth D46 to discover how our tailor-made solutions can support your research and drug development efforts. BioFIT Event #BioFIT2024 #MultiOmics #Innovation #LifeSciences #Biotech #Healthcare

At Firalis Molecular Precision, we prioritize secure, efficient, and client-centered data handling. Today, we’re answering one of the most common questions we receive about our bioinformatics services : How will the #omics data be sent and which type of data will be sent to our clients ? Stay tuned as we address more of your frequently asked questions in our upcoming posts. Have a question you’d like us to cover? Let us know in the comments! #Bioinformatics #MultiOmics #DataManagement #FAQ

December is here—a time to look back on 2024 and celebrate the milestones your lab achieved. It’s also the perfect moment to reflect on what’s next and set goals to make 2025 even better. ✨ Tell us about your New Year resolution and let us help you achieve it!

At Firalis Molecular Precision, we handle highly sensitive and complex omics datasets daily, and secure, efficient storage is a top priority. Today, we’re answering one of the most common questions we receive about our bioinformatics services : How are the datasets stored at Firalis Molecular Precision? Stay tuned as we address more of your frequently asked questions in our upcoming posts.  Have a question you’d like us to cover? Let us know in the comments! #Bioinformatics #OmicsData #Datastorage #DataAnalysis